JP Morgan Chase’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Buy
33,674
+6,526
+24% +$595K ﹤0.01% 4095
2025
Q4
$3.53M Sell
27,148
-646
-2% -$88.7K ﹤0.01% 3626
2025
Q3
$2.99M Buy
27,794
+7,592
+38% +$827K ﹤0.01% 3772
2025
Q2
$1.86M Buy
20,202
+6,432
+47% +$505K ﹤0.01% 3968
2025
Q1
$1.22M Sell
13,770
-94,121
-87% -$8.17M ﹤0.01% 4214
2024
Q4
$8.29M Buy
107,891
+55,730
+107% +$3.89M ﹤0.01% 2875
2024
Q3
$2.21M Buy
52,161
+44,889
+617% +$1.52M ﹤0.01% 3924
2024
Q2
$190K Buy
7,272
+7,238
+21,288% +$137K ﹤0.01% 5187
2024
Q1
$310 Hold
34
﹤0.01% 6770
2023
Q4
$94 Hold
34
﹤0.01% 7131
2023
Q3
$124 Sell
34
-37
-52% -$203 ﹤0.01% 6890
2023
Q2
$424 Sell
71
-6,831
-99% -$54.1K ﹤0.01% 6558
2023
Q1
$83K Buy
6,902
+3,520
+104% +$46.9K ﹤0.01% 5512
2022
Q4
$29K Sell
3,382
-2,307
-41% -$50.8K ﹤0.01% 5769
2022
Q3
$165K Buy
5,689
+132
+2% +$6.04K ﹤0.01% 5044
2022
Q2
$232K Buy
5,557
+4,465
+409% +$303K ﹤0.01% 4998
2022
Q1
$111K Buy
1,092
+112
+11% +$12.4K ﹤0.01% 5460
2021
Q4
$144K Buy
+980
New +$219K ﹤0.01% 5523
2021
Q1
Sell
-2,521
Closed -$919K 6392
2020
Q4
$919K Buy
+2,521
New +$878K ﹤0.01% 4021

Other funds holding WGS

JP Morgan Chase's WGS Position: Q1 2026 in Review

JP Morgan Chase increased its GeneDx Holdings (WGS) stake by 24% in Q1 2026, buying an estimated $595K and bringing the position to 33,674 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #4095.

JP Morgan Chase first reported a position in WGS in Q4 2020 and has held it in 19 quarters since. The position peaked at $8.29M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • JP Morgan Chase held 33,674 shares of GeneDx Holdings worth $2.01M as of Q1 2026.
  • JP Morgan Chase bought 6,526 GeneDx Holdings shares in Q1 2026, an estimated $595K.
  • GeneDx Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4095 holding.
  • JP Morgan Chase first reported a position in GeneDx Holdings in Q4 2020 and has held it in 19 quarters since.
  • JP Morgan Chase's GeneDx Holdings position peaked at $8.29M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.